Cancer incidence in Germany attributable to human papillomavirus in 2013

by Nina Buttmann-Schweiger, Yvonne Deleré, Stefanie J. Klug, Klaus Kraywinkel
Published 2017-10-01

Mucosal and cutaneous Human Papillomavirus seroprevalence among adults in the prevaccine era in Germany — Results from a nationwide population-based survey

by Anna D. Loenenbach, Christina Poethko-Müller, Michael Pawlita, Michael Thamm, Thomas Harder, Tim Waterboer, Juliane Schröter, Yvonne Deleré, Ole Wichmann, Miriam Wiese-Posselt
Published 2019-06-01

Cost-effectiveness of human papillomavirus vaccination in Germany

by Oliver Damm, Johannes Horn, Rafael T. Mikolajczyk, Mirjam E. E. Kretzschmar, Andreas M. Kaufmann, Yvonne Deleré, Bernhard Ultsch, Ole Wichmann, Alexander Krämer, Wolfgang Greiner
Published 2017-09-01

Serological evidence of asymptomatic infections during Escherichia coli O104:H4 outbreak in Germany in 2011.

by Yanina Balabanova, Stefanie Klar, Yvonne Deleré, Hendrik Wilking, Mirko S Faber, Sofie Gillesberg Lassen, Andreas Gilsdorf, Susann Dupke, Martin Nitschke, Friedhelm Sayk, Roland Grunow, Gérard Krause
Published 2013-01-01